Kevin Nishimoto
Publications by Year
Research Areas
CAR-T cell therapy research, Immunotherapy and Immune Responses, Immune Cell Function and Interaction, RNA Interference and Gene Delivery, T-cell and B-cell Immunology
Most-Cited Works
- → Off-the-shelf Vδ1 gamma delta T cells engineered with glypican-3 (GPC-3)-specific chimeric antigen receptor (CAR) and soluble IL-15 display robust antitumor efficacy against hepatocellular carcinoma(2021)178 cited
- → Stress, Immunity, and Cervical Cancer: Biobehavioral Outcomes of a Randomized Clinical Trail(2008)134 cited
- → Immune responses and long‐term disease recurrence status after telomerase‐based dendritic cell immunotherapy in patients with acute myeloid leukemia(2017)105 cited
- → Allogeneic CD20‐targeted γδ T cells exhibit innate and adaptive antitumor activities in preclinical B‐cell lymphoma models(2022)104 cited
- → Generation of Immunogenic Dendritic Cells from Human Embryonic Stem Cells without Serum and Feeder Cells(2009)58 cited
- → Restricted and Selective Tropism of a Venezuelan Equine Encephalitis Virus-Derived Replicon Vector for Human Dendritic Cells(2007)34 cited
- → Gangliosides as targets for immunotherapy for pancreatic adenocarcinoma(2000)30 cited
- → Fluorescence activated cell sorting (FACS) using RNAlater to minimize RNA degradation and perturbation of mRNA expression from cells involved in initial host microbe interactions(2007)22 cited
- → Interleukin-2 Binds to Ganglioside GD1b(2001)21 cited
- → A Human Dendritic Cell Subset Receptive to the Venezuelan Equine Encephalitis Virus-Derived Replicon Particle Constitutively Expresses IL-32(2008)20 cited